Evidence map›Paper›PMID 42526873›Full record

ArticleAnimal bioscience2026

Enzyme-treated soybean meal in diets for weanling pigs: review.

Leidy J Torres-Mendoza, Hans H Stein

Abstract read
In one paragraph

Article in Animal bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leidy J Torres-MendozaDepartment of Animal Sciences, University of Illinois, Urbana, IL, USA.
Hans H SteinDepartment of Animal Sciences, University of Illinois, Urbana, IL, USA. hstein@illinois.edu.

Funding

Hamlet Protein
6 · The paper itself

Abstract

The objective of the present contribution is to provide a summary of the nutritional value of enzyme-treated soybean meal (ESBM) and review effects of ESBM on growth performance of weanling pigs. Guidelines for inclusion rates of ESBM in diets for weanling pigs will also be provided based on the published literature. The literature review was conducted in May 2024 by searching Google Scholar and PubMed for experiments in which ESBM was included in diets for weanling pigs, using Boolean queries implemented with Biopython/Entrez. A total of 24 unique papers were identified. These papers were manually reviewed to verify their relevance to the specific topics of composition, digestibility, and health/performance outcomes. Enzyme-treated soybean meal contains 48.3% to 57.7% crude protein, is rich in amino acids, and has elevated small-peptide fractions. Antinutritional factors such as raffinose and stachyose were reduced by 50% and 90%, respectively, compared with conventional soybean meal (SBM), and trypsin inhibitors are reduced to 1.7 units per mg. Enzyme-treated SBM also contains more fiber, but less monosaccharides and oligosaccharides, than SBM. Enzyme-treated SBM was associated with fewer gastrointestinal disturbances, favorable changes in intestinal microbiota, and improved intestinal barrier indices. In most experiments, pigs fed ESBM had improved growth performance and less diarrhea compared with pigs fed diets containing conventional SBM. Most experiments that examined the nutritional value of ESBM concluded that ESBM supports improved nutrient utilization, growth performance, and health in weanling pigs and on average, inclusion rates of 4% to 10% is recommended. In conclusion, Enzyme-treated SBM has greater concentration of protein and contains fewer antinutritional factors than conventional SBM, which results in greater intestinal health and improved growth performance of weanling pigs if the inclusion rate of ESBM is 4% to 10% in diets for newly weaned pigs.

Indexed as

Anti-nutritional FactorDigestibilityEnzyme-treated Soybean MealSoybean MealWeanling Pigs

Identifiers

PMID42526873
PMCPMC13662934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.